Biotechnology conferences give attendees opportunities to hear knowledge leaders deliver fascinating talks, check out the newest product-related advancements, network with peers and more. If you’re thinking about attending at least one of these events this year, here are some to seriously consider.
As may be obvious from the euro symbol in the event’s name, this conference is geared towards “financial dealmakers,” as well as pharmaceutical executives. It happens on May 11, 2020, at Ireland’s The Convention Centre Dublin. The upcoming 21st edition of this conference promises plenty of time for people to press the flesh with like-minded individuals.
Also, more than 80 companies will give presentations about their offerings. People should anticipate exposure to some of the latest biotech inventions, including some that could prove to be the “next big things.” People can register for the conference at the event’s website, and sign up by Feb. 14, 2020, to take advantage of early-bird rates.
This is a biotech event offered by Financial Times that people can mark on their calendars for May 14, 2020. The summit is the second of its kind, and it happens at New York City’s Stewart Hotel. According to the provided details about last year’s inaugural summit, most individuals who attend are senior-level executives from a range of sectors and specialties. You’ll have chances to meet and hear people from areas including government health care, medical devices and health insurance.
One of the major topics covered at this year’s event is China, and whether the company will soon emerge as a leader in the biotechnology space. Gene editing is another discussion on the agenda, and people will weigh in about drawing the line between opportunity and risk.
People may also find it worthwhile to head to San Diego, California to go to this conference, which happens from June 8-11, 2020, at the San Diego Convention Center. Registration is now open at the event’s website, and previous years attracted more than 17,000 attendees. Plus, more than 8,400 companies had representatives at the event.
Once people sign up for the conference, they can also avail of an opportunity called BIO One-on-One Partnering. Starting in early April, people get information about which individuals will make themselves available for partnering. That means interested parties can reserve available slots to talk to those associated with particular businesses and have 25-minute meetings with them.
This gathering takes place on Nov. 18-19, 2020, in Barcelona, Spain. The event is for people in academia and the business or investment sides of the biotech industry. People can register now at the conference website, and early bird registration is open until May 1, 2020. The organizers have not yet confirmed the event venue, but people interested in potentially going should stay tuned to the website for further details.
The speakers on the schedule so far hail from Israel, Brazil and Spain. There’s also a list of major sessions that potential attendees can explore. The topics include biotechnology in dentistry, environmental biotechnology, using biotechnology as a tool to fight rare diseases and genetic disorders and many more.
The perfect time to plan
Even if you haven’t chosen a shortlist of 2020 biotech conferences yet, now is an ideal time to get started. Regardless of your investing experience, success often requires being ahead of the curve and seeing the promise in new ideas and products before most others do. A conference could give you excellent chances to do that and perhaps even find the next product or company that deserves your investment.
Whether you decide to go to one of the conferences listed here or another event, commit in advance to immersing yourself in the happenings and making the most of them. By taking that approach, you’ll be well-positioned to learn, grow and discover while seeing what’s new in the exciting world of biotechnology.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Candriam excludes 40 percent of all emerging markets
In a report, Bloomberg has used the Candriam SRI Bond Emerging Markets Fund as an example of how active fund...
What is the scope of the CFA franc reform in West Africa
The monetary system of the CFA franc zone, in general, is increasingly challenged, with France being accused of still maintaining...
Europe’s stock exchanges are in an optimal window to buy, says analyst
The declines of more than 3% during some moments of the session led the main stock markets of the Old...
The fintech company Joonko to cease operations after only 12 months of existence
The October 28th press release published by Joonko stated that the Series A financing round with existing and new investors,...
Asabys Partners leads a round of $20 million in Sidekick
Asabys has recently led a successful round of financing in Sidekick, a company specialized in digital therapies. This round will...
Featured6 days ago
Savills IM refinances two Italian assets with one of the first green loans in Italy
Business6 days ago
4 tips to market your small business locally
Business5 days ago
Major reasons why your website might not be attracting customers
Biotech5 days ago
Roche signs its new diabetes business manager in Spain to Isdin